Document is current
Any future updates will be listed below
-
Authors
Antcliffe, David B. https://orcid.org/0000-0002-1846-9160
Harte, Elsa
Hussain, Humma
Jiménez, Beatriz
Browning, Charlotte
Gordon, Anthony C.
-
Funding
Funding for this research was provided by:
NIHR Imperial Biomedical Research Centre
Efficacy and Mechanism Evaluation Programme (16/33/01, 08/99/08, 11/14/08)
Research for Patient Benefit Programme (PB-PG-0610-22350)
NIHR (NIHR/CS/009/007, RP-2015-06-018)
Intensive Care Society
Association of Anaesthetists (John Snow Anaesthesia Intercalated Award)
British Journal of Anaesthesia (John Snow Intercalated Award)
Royal College of Anaesthetists (John Snow Intercalated Award)
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 7 March 2025
First Online: 31 March 2025
Declarations
:
: ACG reports that he has received speaker fees from Orion Corporation Orion Pharma and Amomed Pharma. He has consulted for Ferring Pharmaceuticals, Tenax Therapeutics, and received grant support from Orion Corporation Orion Pharma, and Tenax Therapeutics with funds paid to his institution. All other authors declare no conflict of interest directly applicable to this research.
